Posttranslational elevation of cytochrome P450 3A levels and activity by dimethyl sulfoxide

Archives of Biochemistry and Biophysics

Volumn 353, Issue 1, 1998, Pages 1-9

  Zangar, Richard C ^a   Novak, Raymond F ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

CYP3A; Cytochrome P450; Dimethyl sulfoxide; Hepatocytes; Testosterone hydroxylase

Indexed keywords

CYCLOHEXIMIDE; DIMETHYL SULFOXIDE;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; HYDROXYLATION; LIVER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS; TESTOSTERONE METABOLISM;

EID: 0031830107     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1997.0571     Document Type: Article

References (39)

1. Guengerich F. P. Cytochrome P450: Structure, Mechanism, and Biochemistry. 1995;Plenum Press, New York. p. 473-535.
2. Spatzenegger M., Jaeger W. Drug Metab. Rev. 27:1995;397-417.
3. Burger H.-J., Schuetz J. D., Schuetz E. G., Guzelian P. S. Proc. Natl. Acad. Sci. USA. 89:1992;2145-2149.
4. Talhada M. B., Pereira T. M., Lechner M. C. Arch. Biochem. Biophys. 298:1992;715-725.
5. Watkins P. B., Wrighton S. A., Schuetz E. G., Maurel P., Guzelian P. S. J. Biol. Chem. 261:1986;6264-6271.
6. Yu Z.-W., Quinn P. J. Biosci. Rep. 14:1994;259-281.
7. Brayton C. F. Cornell Vet. 76:1986;61-90.
8. Zangar R. C., Hernandez M., Novak R. F. Biochem. Biophys. Res. Commun. 231:1997;203-205.
9. Zangar R. C., Woodcroft K. J., Kocarek T. A., Novak R. F. Drug Metab. Dispos. 23:1995;681-687.
10. Waxman D. J., Morrissey J. J., Naik S., Jauregui O. H. Biochem. J. 271:1990;113-119.
11. Wrobleski F., LaDue J. S. Proc. Soc. Exp. Biol. Med. 90:1955;210-213.
12. Zangar R. C., Springer D. L., Buhler D. R. J. Toxicol. Environ. Health. 38:1993;43-55.
13. Hulla J. E., Juchau M. R. Biochemistry. 28:1989;4871-4879.
14. Xie W., Rothblum L. I. Biotechniques. 11:1991;324-327.
15. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
16. Doehmer J., Dogra S., Freidberg T., Monier S., Adesnik M., Glatt H., Oesch F. Proc. Natl. Acad. Sci. USA. 85:1988;5769-5773.
17. Hardwick J. P., Song B.-J., Huberman E., Gonzalez F. J. J. Biol. Chem. 262:1987;801-810.
18. Balmain A., Krumlauf R., Vass J. K., Birnie G. D. Nucleic Acids Res. 10:1982;4259-4277.
19. Vind C., Dich J., Grunnet N. Arch. Biochem. Biophys. 275:1989;140-150.
20. Zangar R. C., Buhler D. R., Springer D. L. J. Toxicol. Environ. Health. 45:1995;47-58.
21. Kim S. G., Shenin S. E., States J. C., Novak R. F. Biochem. Biophys. Res. Commun. 172:1990;767-774.
22. Eberhart D. C., Parkinson A. Arch. Biochem. Biophys. 291:1991;231-240.
23. Waxman D. J. Biochem. Pharmacol. 37:1988;71-84.
24. Murray M., Horstfield B. P. J. Steroid Biochem. 36:1990;569-574.
25. Bond G. R., Curry S. C. Lancet. 1:1989;1134-1135.
26. Salim A. S. J. Lab. Clin. Med. 119:1992;702-709.
27. Salim A. S. J. Lab. Clin. Med. 119:1992;710-717.
28. Salim A. S. Chemotherapy. 38:1992;127-134.
29. Salim A. S. Chemotherapy. 38:1992;135-144.
30. Hucker H. B., Miller J. K., Hochberg A., Brobyn R. D., Riordan F. H., Calesnick B. J. Pharmacol. Exp. Ther. 155:1967;309-317.
31. Hucker H. B., Ahmad P. M., Miller E. A. J. Pharmacol. Exp. Ther. 154:1966;176-184.
32. Kolb K. H., Jaenicke G., Kramer M., Schulze P. E. Ann. N.Y. Acad. Sci. 141:1967;85-95.
33. Martindale. Reynolds J. E. F. The Extra Pharmacopoeia. 1996;1399-1400 Royal Pharm. Soc. London.
34. Eliasson E., Mkrtchian S., Halpert J., Ingleman-Sundberg M. J. Biol. Chem. 269:1994;18378-18383.
35. Windholz M. Merck Index, 10th ed. 1983;Merck, Rahway. p. 1395.
36. Lindsay C. K., Chenery R. J., Hawksworth G. M. Biochem. Pharmacol. 42:1991;S17-S25.
37. Jeong T. C., Jeong H. G., Yang K.-H. Toxicol. Lett. 61:1992;275-281.
38. Kocarek T. A., Schuetz E. G., Guzelian P. S. Biochem. Pharmacol. 48:1994;1815-1822.
39. Sidhu J. S., Omiecinski C. J. Pharmacogenetics. 5:1995;24-36.